Onsanit S, Wanichang K, Anutarapongpan K. Cost-Effectiveness of Crystalline and Amorphous Atorvastatin in the Secondary Prevention of Cardiovascular Disease. SRIMEDJ [Internet]. 2019 May 3 [cited 2024 May 4];34(3):219-25. Available from: https://li01.tci-thaijo.org/index.php/SRIMEDJ/article/view/187217